The Expecto Health Science team attended the ASMA | Annual Summit on Medical Affairs 2025 in Singapore, engaging in insightful discussions on the future of Medical Affairs, AI and digital…
Expecto Health Science attended ESMO Asia 2025, gaining valuable insights into emerging oncology therapies and clinical research trends across the APAC region. The conference supported our ongoing commitment to advancing…
Expecto Health Science is pleased to announce that it has received the License to Operate as a Contract Research Organization (CRO) from the Philippines Food and Drug Administration (FDA). This…
